The onslaught of new genomic biotechnologies, which show promise for correcting some serious health disorders, also challenge scientists to confront important social responsibilities.
George Q. Daley, M.D., Ph.D., dean of Harvard Medical School and an international leader in stem cell science and cancer biology, discussed those responsibilities in Dean Henri R. Ford’s Distinguished Lecture Series, reflecting on many decades of exploration at the interface of science, policy, ethics, and beyond.
Molecular activation triggers for dangerous bacteria like V.cholerae and E.coli were highlighted at the opening presentation of the “Miami Winter Symposium 2020: Molecular Mechanisms Linking the Microbiome and Human Health,” January 26-29 at the Hyatt Regency Miami.
Statins are well-known medications that can help people lower high cholesterol levels. Now a new study shows a topical formulation of mevastatin in development could help heal chronic skin wounds. University of Miami Miller School of Medicine researchers report the novel discovery in the journal JCI Insight.
A study analyzing new evolutionary complexity in uveal melanoma by J. William Harbour, M.D., associate director for basic science at the NCI-designated Sylvester Comprehensive Cancer Center, and professor of ophthalmology, and vice chair and director of ocular oncology at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine was published today.
With the cutting of a broad ribbon, a new era of breakthrough research and clinical treatment became a reality at Bascom Palmer Eye Institute’s brand-new Lois Pope Center for Retinal and Macular Degeneration Research, a 21,000-square-foot facility dedicated to ending blinding retinal diseases.
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine is adding to its academic credentials with a prestigious new fellowship in urologic oncology.